Literature DB >> 7644856

The analysis of repeated-measures data on schizophrenic reaction times using mixture models.

T R Belin1, D B Rubin.   

Abstract

Reaction times for schizophrenic individuals in a simple visual tracking experiment can be substantially more variable than for non-schizophrenic individuals. Current psychological theory suggests that at least some of this extra variability arises from an attentional lapse that delays some, but not all, of each schizophrenic's reaction times. Based on this theory, we pursue models in which measurements from non-schizophrenics arise from a normal linear model with a separate mean for each individual, whereas measurements from schizophrenics arise from a mixture of (i) a component analogous to the distribution of response times for non-schizophrenics and (ii) a mean-shifted component. We fit four mixture models within this framework, where the distinctions between models arise from assumptions about the variance of the shifted observations and the exchangeability of schizophrenic individuals. Some of these models can be fit by maximum likelihood using the EM algorithm, and all can be fit using the ECM algorithm, where the covariance matrices associated with the parameters are calculated by the SEM and SECM algorithms, respectively. Bayesian model monitoring using posterior predictive checks is invoked to discard models that fail to reproduce certain observed features of the data and to stimulate the development of better models.

Entities:  

Mesh:

Year:  1995        PMID: 7644856     DOI: 10.1002/sim.4780140805

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

Review 1.  Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

Authors:  Karl Brendel; Céline Dartois; Emmanuelle Comets; Annabelle Lemenuel-Diot; Christian Laveille; Brigitte Tranchand; Pascal Girard; Céline M Laffont; France Mentré
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  A hierarchical finite mixture model that accommodates zero-inflated counts, non-independence, and heterogeneity.

Authors:  Charity J Morgan; Mark F Lenzenweger; Donald B Rubin; Deborah L Levy
Journal:  Stat Med       Date:  2014-01-20       Impact factor: 2.373

3.  A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer.

Authors:  Satoshi Morita; Peter F Thall; B Nebiyou Bekele; Paul Mathew
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2009-09-03       Impact factor: 1.864

4.  Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check.

Authors:  Y Yano; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-04       Impact factor: 2.745

5.  INTERMITTENT DEGRADATION AND SCHIZOTYPY.

Authors:  Matthew W Roché; Steven M Silverstein; Mark F Lenzenweger
Journal:  Schizophr Res Cogn       Date:  2015-06-01

6.  Examining the Association between Patient-Reported Symptoms of Attention and Memory Dysfunction with Objective Cognitive Performance: A Latent Regression Rasch Model Approach.

Authors:  Yuelin Li; James C Root; Thomas M Atkinson; Tim A Ahles
Journal:  Arch Clin Neuropsychol       Date:  2016-04-24       Impact factor: 2.813

7.  Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations.

Authors:  D R Mould; A-C Walz; T Lave; J P Gibbs; B Frame
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-01-21

8.  Estimating mono- and bi-phasic regression parameters using a mixture piecewise linear Bayesian hierarchical model.

Authors:  Rui Zhao; Paul Catalano; Victor G DeGruttola; Franziska Michor
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.